Giovanni Cacciamani

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Giovanni Cacciamani

Jan 12, 2025, 15:38 | Insight

Danielle Bitterman: TRIPOD-LLM consensus guidelines for reporting LLM research in biomedicine

Danielle Bitterman, Assistant Professor at Harvard Medical School, posted on LinkedIn: “TRIPOD-LLM is out in…

Jan 10, 2025, 15:32 | Science

Danielle Bitterman: Consensus guidelines for reporting LLM research in biomedicine

Danielle Bitterman, Assistant Professor at Harvard Medical School, posted on X about recent paper by…

Jul 26, 2024, 19:55 | Insight

Giovanni Cacciamani: Readability of patient education materials in uro-oncology

Giovanni Cacciamani, Director of AI Center at USC Urology, shared a post on X about…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023